Our mission is to better patients prescription adherence that could translate into a healthier and prosperous life.


Page 1
Company
Products and Services
Management
Investors Relations
Contacts us
Press Release
Francais

DoseWatch smart blister card offers to clinicians a patient adherence tool that will ultimately translate into manageable data through our sophisticated proprietary software and data management system. Adherence levels and other data can be accessed without the need to have the patient's presence. Virtually, a clinician can access his enrolled patient's adherence data from his desk using his/her own personal PC.

DoseWatch smart packaging does not interfere with the patient ability to take his/her medications.  This state of the art technology's "behind the scene phantom" keeps track of all blister punch events by recording the time frequency and other pertinent data analysis.  Upon completion, the patient reports a coded adherence number appearing in his/her blister. The clinician from the comfort of his desk input the adherence code, and let our sophisticated software system interprets the patient adherence frequencies and level.  Multiple tasks can be achieved and printed whether a pie chart, a statistical interpretation, a graph or any adherence information needed by the clinician. 

As your dedicated partner in your pharmaceutical research and development process, and given that patient non-adherence is mostly due to the patient forgetting to take his/her medication, DoseWatch enabled  technology will automatically remind the patient to  observe adherence on every scheduled dose. Our commitment is to achieving optimum level of satisfaction to both clinicians and patients through our dedicated efforts by working hand in hand with your organization.   

DoseWatch Corporation is well aware of widespread non adherence during clinical trials given the reliance on the volunteer's willingness to participate in research. However, with our state of the art technology, research scientists will be able to detect patient adherence levels and increase the quality of clinical trial results which are dependent on the quality of adherence data.